The goal of this observational study is to learn the long-term prognosis of patients and the clinical characteristics of complications, which is of great significance for treatment of novel coronavirus infection pneumonia. This trial plans to include 5700 inpatients with positive SARS CoV-2 nucleic acid test results. This trial does not involve the use of specific drug. Participants's health and psychological status will be observed at the preset time points. The blood, feces, urine samples of patients will be collected for relevant tests.
After the patients are enrolled, record the patient's treatment regimens, blood routine results, blood biochemistry results, cytokines results, lung imaging results, and cranial imaging results, understand the patient's current clinical manifestations, evaluate the patient's psychological status and quality of life, and collect samples of the patients' blood, feces, urine, and other related tests. Collection of clinical samples: collect blood, urine, throat swabs and other samples from patients with confirmed novel coronavirus pneumonia (Nucleic acid test positive), and collect samples for relevant tests at 3 months, 6 months, 12 months, 18 months, 24 months and 36 months after discharge of patients, and record the clinical manifestations of patients.
Study Type
OBSERVATIONAL
Enrollment
5,700
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Wuhan, Hubei, China
RECRUITINGWuhan Seventh Hospital
Wuhan, Hubei, China
RECRUITINGclinical manifestation
Time frame: 3 months, 6 months, 12 months, 18 months, 24 months, 36 months after patients discharge
psychological status
Time frame: 3 months, 6 months, 12 months, 18 months, 24 months, 36 months after patients discharge
quality of life scores
Time frame: 3 months, 6 months, 12 months, 18 months, 24 months, 36 months after patients discharge
cranial imaging results
Time frame: 3 months, 6 months, 12 months, 18 months, 24 months, 36 months after patients discharge
lung imaging results
Time frame: 3 months, 6 months, 12 months, 18 months, 24 months, 36 months after patients discharge
cytokines level
Time frame: 3 months, 6 months, 12 months, 18 months, 24 months, 36 months after patients discharge
blood biochemistry results
Time frame: 3 months, 6 months, 12 months, 18 months, 24 months, 36 months after patients discharge
routine blood test results
Time frame: 3 months, 6 months, 12 months, 18 months, 24 months, 36 months after patients discharge
treatment regimens
Time frame: 3 months, 6 months, 12 months, 18 months, 24 months, 36 months after patients discharge
survival rate
Time frame: 3 months, 6 months, 12 months, 18 months, 24 months, 36 months after patients discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.